Squarepoint’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,799
Closed -$127K 4782
2025
Q4
$127K Sell
10,799
-12,701
-54% -$110K ﹤0.01% 3992
2025
Q3
$188K Buy
+23,500
New +$164K ﹤0.01% 3967
2025
Q2
Sell
-3,207
Closed -$22.6K 4907
2025
Q1
$22.6K Buy
3,207
+2
+0.1% +$22 ﹤0.01% 4428
2024
Q4
$36.4K Buy
3,205
+1,809
+130% +$23.6K ﹤0.01% 4892
2024
Q3
$19.5K Buy
+1,396
New +$22.2K ﹤0.01% 4023
2023
Q4
Sell
-3,702
Closed -$48.7K 4363
2023
Q3
$48.7K Buy
3,702
+216
+6% +$3.55K ﹤0.01% 3637
2023
Q2
$65.6K Buy
+3,486
New +$69K ﹤0.01% 3419
2023
Q1
Sell
-586
Closed -$16.2K 3648
2022
Q4
$16.2K Buy
586
+35
+6% +$883 ﹤0.01% 3112
2022
Q3
$14K Buy
+551
New +$21.7K ﹤0.01% 2920
2022
Q2
Sell
-2,325
Closed -$144K 3241
2022
Q1
$144K Sell
2,325
-568
-20% -$46.8K ﹤0.01% 2550
2021
Q4
$367K Buy
2,893
+1,715
+146% +$280K ﹤0.01% 2342
2021
Q3
$235K Sell
1,178
-332
-22% -$79.2K ﹤0.01% 2392
2021
Q2
$400K Sell
1,510
-1,130
-43% -$350K ﹤0.01% 2303
2021
Q1
$923K Buy
2,640
+2,240
+560% +$956K 0.01% 1577
2020
Q4
$205K Sell
400
-144
-26% -$57.7K ﹤0.01% 2496
2020
Q3
$143K Buy
+544
New +$187K ﹤0.01% 2209

Other funds holding PASG

Squarepoint's PASG Position: Q1 2026 in Review

Squarepoint sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 10,799 shares — an estimated $127K sold.

Squarepoint first reported a position in PASG in Q3 2020 and held it in 16 quarters. The position peaked at $923K in Q1 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Squarepoint reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 10,799 Passage Bio shares in Q1 2026, an estimated $127K.
  • Squarepoint first reported a position in Passage Bio in Q3 2020 and held it in 16 quarters.
  • Squarepoint's Passage Bio position peaked at $923K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.